SRJ09, a promising anticancer drug lead: elucidation of mechanisms of antiproliferative and apoptogenic effects and assessment of in vivo antitumor efficacy
SRJ09 (3,19-(2-bromobenzylidene)andrographolide), a semisynthetic andrographolide (AGP) derivative, was shown to induce G1 cell cycle arrest and eventually apoptosis in breast and colon cancer cell lines. The present investigation was carried out to elucidate the mechanisms cell cycle arrest and apo...
保存先:
主要な著者: | , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Elsevier
2016
|
主題: | |
オンライン・アクセス: | http://psasir.upm.edu.my/id/eprint/53871/1/SRJ09%2C%20a%20promising%20anticancer%20drug%20lead.pdf |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|